SWARTZ ROBIN (Chief Operating Officer) sold 3.2% of their position (3.97K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $29.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/22/2024ACC: 0001104659-24-026562
Officer· Chief Operating Officer
Since Feb 2022
-3.97K
Net shares
Net seller
$29.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.97K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.97K
Price / share
$7.45
Trade value
$29.55K
% of position
3.2%
2/21/2024
122.33K→118.36K
Total
Net shares
−3.97K
Net value
-$29.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2024 | S · Sale | −3.97K | $7.45 | $29.55K | 3.2% | 122.33K | 118.36K |
| Total | −3.97K | -$29.55K | ||||||
Derivative Transactions0
No derivative transactions reported